KYAT1 and cancer: Some inhibitors have been designed to inhibit GTK/KAT1 (based on kynurenine as amino acid substrate) with Ki values ranging from ~20 μM to ~1 mM [63], but to our knowledge these have not been evaluated as anti-cancer agents.